[Evisceration and secondary enucleation with implantation following endophthalmitis].
OBJECTIVE
Primary evisceration followed by secondary enucleation and implant placement makes it possible to use the sclera of a patient with endophthalmitis. This sclera will be used for secondary implantation.


METHODS
Four patients with endophthalmitis and corneal perforation (bacterial infection in three cases and fungal infection in one case) underwent evisceration and, 4-6 weeks later, enucleation. During the secondary enucleation, the sclera was recovered and used as wrapping material for the alumina implant (Al2O3) (20 and 22 mm in diameter). Between the two operations, the patients were treated with systemic and topical antibiotics or antifungal agents.


RESULTS
No complications were observed for both the first and the second operation. Enucleated sclera was crumpled and bent in all four cases. The sclera was spread out and used as wrapping material. Prosthetic fitting was performed 4-5 weeks after the second operation. No complications have been observed to date (10 to 32 months follow-up).


CONCLUSIONS
Primary implantation following endophthalmitis is debatable because an infectious complication cannot be excluded. The use of sclera for implant wrapping decreases the risk of implant extrusion, especially when the conjunctiva and Tenon's facia have been weakened by previous surgery or infection. Primary evisceration with a conformer placement followed by enucleation and implantation is an ideal solution in endophthalmitis because this technique allows the use of patient's own sclera.
Gaillard
M-C
MC
Hôpital Ophtalmique Jules Gonin, Lausanne, Suisse.
Gianoli
F
F
Spahn
B
B
D000368:Aged; D000369:Aged, 80 and over; D003316:Corneal Diseases / Q000382:microbiology* / Q000601:surgery; D009877:Endophthalmitis / Q000382:microbiology / Q000601:surgery*; D015353:Eye Enucleation; D015821:Eye Infections, Fungal / Q000601:surgery*; D006801:Humans; D008297:Male; D020273:Orbital Implants; D012086:Reoperation; D016896:Treatment Outcome